There exists tremendous opportunity to target microorganisms in the gut and other niches to help treat or even prevent cancer. This Review outlines how microbial targeting could become a pillar of personalized cancer care over the next 5 to 10 years.
- Elizabeth M. Park
- Manoj Chelvanambi
- Jennifer A. Wargo
